2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert …

MM Cloutier, AP Baptist, KV Blake, EG Brooks… - Journal of Allergy and …, 2020 - Elsevier
The 2020 Focused Updates to the Asthma Management Guidelines: A Report from the
National Asthma Education and Prevention Program Coordinating Committee Expert Panel …

Asthma outcomes: biomarkers

SJ Szefler, S Wenzel, R Brown, SC Erzurum… - Journal of Allergy and …, 2012 - Elsevier
BACKGROUND: Measurement of biomarkers has been incorporated within clinical research
studies of asthma to characterize the population and associate the disease with …

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials …

HK Reddel, DR Taylor, ED Bateman… - American journal of …, 2009 - atsjournals.org
Background: The assessment of asthma control is pivotal to the evaluation of treatment
response in individuals and in clinical trials. Previously, asthma control, severity, and …

Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients

G Jia, RW Erickson, DF Choy, S Mosesova… - Journal of Allergy and …, 2012 - Elsevier
BACKGROUND: Eosinophilic airway inflammation is heterogeneous in asthmatic patients.
We recently described a distinct subtype of asthma defined by the expression of genes …

2020 NAEPP guidelines update and GINA 2021—asthma care differences, overlap, and challenges

BE Chipps, KR Murphy, J Oppenheimer - The Journal of Allergy and …, 2022 - Elsevier
The 2020 National Asthma Education and Prevention Program Coordinating Committee
Expert Panel Working Group (NAEPP [2020 Focused Asthma Update]) guidelines and the …

A large subgroup of mild-to-moderate asthma is persistently noneosinophilic

KW McGrath, N Icitovic, HA Boushey… - American journal of …, 2012 - atsjournals.org
Rationale: Airway eosinophilia is typical of asthma, and many controller treatments target
eosinophilic disease. Asthma is clinically heterogeneous, however, and a subgroup of …

Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence

LK Williams, EL Peterson, K Wells… - Journal of Allergy and …, 2011 - Elsevier
BACKGROUND: Asthma is an inflammatory condition often punctuated by episodic
symptomatic worsening, and accordingly, patients with asthma might have waxing and …

Asthma outcomes: exacerbations

A Fuhlbrigge, D Peden, AJ Apter, HA Boushey… - Journal of Allergy and …, 2012 - Elsevier
BACKGROUND: The goals of asthma treatment include preventing recurrent exacerbations.
Yet there is no consensus about the terminology for describing or defining “exacerbation” or …

Global trends in the incidence and mortality of asthma from 1990 to 2019: An age-period-cohort analysis using the global burden of disease study 2019

Y Cao, S Chen, X Chen, W Zou, Z Liu, Y Wu… - Frontiers in Public …, 2022 - frontiersin.org
Background Asthma is a major global health challenge. The global strategic management
and prevention of asthma report has been published, but health system planning for asthma …

Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial

FD Martinez, VM Chinchilli, WJ Morgan, SJ Boehmer… - The Lancet, 2011 - thelancet.com
Background Daily inhaled corticosteroids are an effective treatment for mild persistent
asthma, but some children have exacerbations even with good day-to-day control, and many …